...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Discussion Forum: Zenith Epigenetics
Message Title
Rating
Author / Date
2
Oct 30, 2022 03:42PM
2
Oct 30, 2022 01:47PM
3
Oct 30, 2022 01:28PM
2
Oct 30, 2022 01:22PM
1
Oct 30, 2022 12:56PM
2
Oct 30, 2022 12:25PM
1
Oct 30, 2022 12:19PM
3
Oct 30, 2022 12:07PM

Oct 30, 2022 11:38AM

Oct 30, 2022 11:26AM
4
Oct 30, 2022 11:08AM
3
Oct 30, 2022 09:54AM
1
Oct 30, 2022 06:27AM
5
Oct 29, 2022 03:45PM
2
Oct 29, 2022 02:49PM

Oct 29, 2022 02:36PM
2
Oct 29, 2022 11:18AM
3
Oct 29, 2022 08:17AM

Oct 29, 2022 06:54AM
2
Oct 28, 2022 10:15PM